News | Contrast Media | July 17, 2017

Latest version offers new chapter on contrast-enhanced ultrasound, updates on patient selection and preparation strategies, and more

ACR Offers Revised Contrast Media in Imaging Manual

July 17, 2017 — The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of contrast media.

“Changes in technology and available scientific evidence prompted the updates in this practical reference,” said James H. Ellis, M.D., FACR, outgoing chair of the ACR Committee on Drugs and Contrast Media.

“The latest version of the manual incorporates multiple practical changes that immediately should improve the practice of radiology by groups who follow these guidelines,” said Matthew S. Davenport, M.D., FSAR, FSCBTMR, incoming chair.

The revised manual has updated chapters on:

  • Patient selection and preparation strategies;
  • Administering contrast media to pregnant or potentially pregnant patients;
  • Use of gadolinium-based contrast media in patients with normal and impaired renal function; and
  • There is also a new chapter addressing contrast-enhanced ultrasound.

The Manual on Contrast Media is available at no charge on the ACR website.

For more information: www.acr.org 


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now